Galmed Pharmaceuticals Ltd (GLMD) Live Share Price, Invest From India

Galmed Pharmaceuticals Ltd Stock Performance

as on May 7, 2026 at 6:59 am IST

Day's Low
Day's High
$0.58
Day's Price Range
$0.65
$0.63
7.94%
Downside
3.17%
Upside
52 Week's Low
52 Week's High
$0.41
52-Week Price Range
$2.34
$0.63
34.75%
Downside
271.43%
Upside

Galmed Pharmaceuticals Ltd share price movements today

Previous Close: $0.59
Open: $0.59
Volume: 688.4K
Day's Low - High: $0.58 - $0.65
52 Week Low - High: $0.41 - $2.34

Galmed Pharmaceuticals Ltd Historical Returns

1 Month Return: + 13.24 %
3 Month Return: -11.13 %
1 Year Return: -59.59 %
3 Year Return: -99.2 %
5 Year Return: -99.88 %

Galmed Pharmaceuticals Ltd Stock Fundamentals & Key Indicators

Check Galmed Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.9M

EPS (TTM)

-1.56

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-64.21%

Galmed Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Galmed Pharmaceuticals Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Galmed Pharmaceuticals Ltd	BUY	$3.9M	-99.88%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.2B	127.94%	75.85	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.9B	99.08%	25.18	32.94%
BeiGene, Ltd.	NA	$33.1B	NA	120.44	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.6B	40.83%	17.13	29.65%

Stock Returns calculator for Galmed Pharmaceuticals Ltd Stock including INR - Dollar returns

The Galmed Pharmaceuticals Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Galmed Pharmaceuticals Ltd investment value today

Current value as on today

₹48,425

Returns

-₹51,575

(-51.57%)

Returns from Galmed Pharmaceuticals Ltd Stock

-₹56,849 (-56.85%)

Dollar Impact

₹5,275 (+5.27%)

Analyst Recommendation on Galmed Pharmaceuticals Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Galmed Pharmaceuticals Ltd. Average target price of $12

Galmed Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on Galmed Pharmaceuticals Ltd.

What analysts predicted

94.75%UPSIDE

Target Price

$12

Current Price

$0.63

Analyzed by

7 Analysts

Target

$12.00

Galmed Pharmaceuticals Ltd target price $12, a slight upside of 94.75% compared to current price of $0.63. According to 7 analysts rating.

Indian Investors' Interest in Galmed Pharmaceuticals Ltd Stock

Investment in Galmed Pharmaceuticals Ltd Shares on INDmoney has grown by 2666.66% in the last 30 days, indicating increased investment activity.

Time period: April 7, 2026 to May 7, 2026

Change:2666.66% versus previous 30 day period

Search interest for Galmed Pharmaceuticals Ltd Stock has increased by 2145% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 7, 2026 to May 7, 2026

Change:2145% versus previous 30 day period

Galmed Pharmaceuticals Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	0	0	-	-	-	-	-	-
Operating Income	-1	-2	-1	-1	-2	-1	-1	-2	-2	-3
EBITDA	-1	-	-1	-1	-2	-	-1	-2	-2	-3
Interest Expense	0	-	-	-	-	-	0	-	-	-
Depreciation	0	0	0	0	-	-	-	-	-	-
Income Before Tax	-1	-2	-1	-1	-1	-3	-1	-2	-1	-4
Income Tax Expense	0	-	0	-	-	-	-	-	-	-
Net Income	-1	-2	-1	-1	-1	-3	-1	-2	-1	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galmed Pharmaceuticals Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	2	-	-	-	-	-	-	-
Gross Profit	0	1	2	0	0	0	0	0	0	-
Operating Income	-16	-12	-10	-22	-30	-32	-17	-7	-6	-8
EBITDA	-16	-12	-10	-22	-30	-32	-17	-7	-6	-8
Interest Expense	0	0	0	0	0	0	0	0	0	-
Depreciation	-	0	0	0	0	0	0	0	0	-
Income Before Tax	-16	-12	-9	-20	-28	-32	-17	-6	-7	-10
Income Tax Expense	0	12	0	-1	-1	0	0	-14	-	-
Net Income	-16	-12	-9	-20	-28	-32	-17	-6	-7	-10
Net Profit Margin	-3630.19%	-1133.55%	-483.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galmed Pharmaceuticals Ltd Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-1	-1	-1	-3	-1	-2	-1	-4
Operating Cash Flow	0	-1	-1	-1	-1	-1	-1	-1	-1
Investing Cash Flow	-	0	1	0	-	0	-4	0	1
Financing Cash Flow	-	-	-	8	0	1	6	0	1
Change in Cash	1	-1	0	7	-5	0	0	-1	0

Galmed Pharmaceuticals Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-9	-20	-28	-32	-17	-6	-7	-10
Operating Cash Flow	-12	-9	-14	-26	-32	-18	-6	-5	-6
Investing Cash Flow	6	-60	6	16	11	17	0	-1	-3
Financing Cash Flow	15	80	0	0	17	0	6	8	9
Change in Cash	9	11	-8	-8	-4	0	0	1	0

Global Institutional Holdings in Galmed Pharmaceuticals Ltd

Funds	Holdings
Two Sigma Investments LLC	1.7%
Citadel Advisors Llc	0.58%
TSFG, LLC	0%
Sontag Advisory LLC	0%
Two Sigma Advisers, LLC	0.48%

See all

Insights on Galmed Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Galmed Pharmaceuticals Ltd has experienced a drawdown of -99.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 91.3%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 85.3%
NEGATIVE IMPACT
Price Dip
In the last 6 months, GLMD stock has moved down by -52.1%

About Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Organisation	Galmed Pharmaceuticals Ltd
Headquarters	16 Abba Hillel Road, Ramat Gan, Israel, 5250608
Industry	Biotechnology
CEO	Mr. Allen Baharaff
E-voting on shares	Click here to vote

Key Management of Galmed Pharmaceuticals Ltd

Name	Title
Mr. Allen Baharaff	Co-Founder, President, CEO & Chairman
Mr. Doron Cohen	Chief Financial Officer
Mr. Guy Nehemya	COO & Data Protection Officer
Mr. Yohai Stenzler CPA	Chief Accounting Officer
Dr. Liat Hayardeny MBA, Ph.D.	Chief Scientific Officer
Dr. Tali Gorfine	Medical Consultant

FAQs

What is Galmed Pharmaceuticals Ltd share price today?

Galmed Pharmaceuticals Ltd share price today is $0.63 as on May 7, 2026 at 1:29 am IST at the close of the market. Galmed Pharmaceuticals Ltd share today touched a day high of $0.65 and a low of $0.58.

What is the 52 week high and 52 week low for Galmed Pharmaceuticals Ltd share?

Galmed Pharmaceuticals Ltd share touched a 52 week high of $2.34 on July 17, 2025 and a 52 week low of $0.41 on March 27, 2026. Galmed Pharmaceuticals Ltd stock price today i.e. May 7, 2026 at 1:29 am IST is closed at $0.63,which is 73.08% down from its 52 week high and 53.25% up from its 52 week low.

What is Galmed Pharmaceuticals Ltd's market capitalisation today?

Galmed Pharmaceuticals Ltd market capitalisation is $0.00T as on May 7, 2026 at 1:29 am IST.

How to invest in Galmed Pharmaceuticals Ltd Stock (GLMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Galmed Pharmaceuticals Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galmed Pharmaceuticals Ltd Shares that will get you 2.3810 shares as per Galmed Pharmaceuticals Ltd share price of $0.63 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Galmed Pharmaceuticals Ltd Stock (GLMD) from India?

Indian investors can start investing in Galmed Pharmaceuticals Ltd (GLMD) shares with as little as ₹94.61 or $1 (as of May 7, 2026 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Galmed Pharmaceuticals Ltd stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 4:37 am IST). Based on Galmed Pharmaceuticals Ltd share’s latest price of $0.63 as on May 7, 2026 at 1:29 am IST, you will get 15.8730 shares of Galmed Pharmaceuticals Ltd. Learn more about fractional shares .

What are the returns that Galmed Pharmaceuticals Ltd has given to Indian investors in the last 5 years?

Galmed Pharmaceuticals Ltd stock has given -99.88% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?